à virion fragmenté)

DRUG3 trials

Sponsors

CHU De Liege, Centre Hospitalier Regional Universitaire De Tours, Centre Hospitalier Universitaire De Saint Etienne

Conditions

Adults seeking active immunisation against the seasonal influenza virusHematological cancerpatients with stable coronary artery disease

Phase 2

Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease - Randomized Delayed-Start Pilot Trial

Active, not recruitingCTIS2024-514543-28-00

Centre Hospitalier Regional Universitaire De Tourspatients with stable coronary artery disease

Start: 2024-10-21Target: 50Updated: 2024-09-16

Phase 3

A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematological Cancer (Flu-Hemato-Rando study)

RecruitingCTIS2023-505357-40-00

CHU De LiegeHematological cancer

Start: 2023-09-18Target: 180Updated: 2023-08-23

Phase 4

Impact of influenza vaccination on nasal resident memory immune responses and respiratory peripheral memory immune responses - MUCOVAC 2

CompletedCTIS2025-521217-46-00

Centre Hospitalier Universitaire De Saint EtienneAdults seeking active immunisation against the seasonal influenza virus

Start: 2025-12-02End: 2026-01-22Target: 30Updated: 2025-12-02